- 15 August 2019
1:00 pm - 2:00 pm
Thursday 15 AUGUST 2019, 1.00 PM
Auditorium, Level 6, Bancroft Building
translational research to improve outcomes for patients with blood cancer
Associate Professor Steven Lane,
QIMR Berghofer Medical Research Institute
Blood cancers are among the most common and lethal cancers in Australia, with 6-7000 deaths per year and a peak in young patients. High risk blood cancers such as aggressive lymphoma or leukaemia usually respond to chemotherapy at initial diagnosis. However, relapsed or refractory disease is associated with chemotherapy resistance and this invariably leads to poor outcomes for patients. This talk will outline some of the translational approaches to blood cancer research in the lab and clinic, focusing on ways to improve survival for patients.
Associate Professor Steven Lane is a clinical haematologist and translational researcher, based out of the Royal Brisbane and Women’s Hospital and QIMR Berghofer Medical Research Institute. His work focuses on understanding molecular drivers of cancer and targeted therapies. He is the Director of Clinical Research in Cancer Care at RBWH, and principal investigator on a number of national cooperative trials. Steven is the Head of the Cancer Program at QIMR Berghofer, and laboratory head of the Gordon and Jessie Gilmour Leukaemia Research Laboratory. His laboratory has been supported by the CSL Centenary Fellowship, NHMRC, Leukaemia Foundation, Cancer Australia and philanthropic donations.